LexDanaLexDanabeta
Inventor

Ezra ROBERTS

Inventor
US

Overview

5→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes19%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium13%
Y02ATechnologies for adaptation to climate change6%
PatentTitleYear
12,570,642GLP-IR modulating compounds202612,497,408Tetracyclic compounds and methods for the treatment of Zika virus infection202512,122,776Tetracyclic compounds and uses thereof202411,858,918GLP-1R modulating compounds202411,697,652Tetracyclic compounds and uses thereof2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2026Patents assigned to GILEAD SCIENCES INC (5)· patent assignee history
2023–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GILEAD SCIENCES INC52023–2026
Locations
LocationPatentsSpan
US52023–2026